⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83145 | 0.81 | — | — | |
| SCHEMBL19343236 | 0.78 | CETP (0.31) | — | |
| SCHEMBL25252075 | 0.78 | CETP (0.32) | — | |
| SCHEMBL22821854 | 0.75 | — | — | |
| SCHEMBL28011558 | 0.74 | ALDH1A1 (0.44) | — | |
| SCHEMBL28818806 | 0.74 | DNM1 (0.31) | — | |
| SCHEMBL798845 | 0.73 | — | — | |
| SCHEMBL2627104 | 0.73 | — | — | |
| SCHEMBL24379479 | 0.71 | — | — | |
| SCHEMBL22482035 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021236543-A1 | TREATMENT FOR AMYLOIDOSIS | RECURIUM IP HOLDINGS, LLC (US) | 2021-11-25 | — | — | WO | disclosed |
| WO-2021127036-A1 | COMBINATIONS | RECURIUM IP HOLDINGS, LLC (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021127041-A1 | COMBINATIONS | RECURIUM IP HOLDINGS, LLC (US) | 2021-06-24 | — | — | WO | disclosed |